Li-Fraumeni Syndrome 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
11
|
0.700 |
None |
1.000 |
2 |
11
|
2001 |
2018 |
Neurofibromatosis 1 and 2 (NF1 and NF2)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
7
|
0.100 |
None |
|
0 |
7
|
|
|
CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
|
disease |
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Refractory anemia with excess blasts I
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
3
|
8
|
0.100 |
None |
|
0 |
1
|
|
|
Abnormality of the tibial metaphysis
|
disease |
|
Anatomical Abnormality
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Type 1 Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
4
|
14
|
0.100 |
None |
|
0 |
2
|
|
|
Abnormality of the femoral metaphysis
|
disease |
|
Anatomical Abnormality
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
increased risk of pancreatic cancer
|
phenotype |
Neoplasms
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
PROSTATE CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
Breast Cancer, Familial Male
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
PROSTATE CANCER, SOMATIC
|
disease |
|
Neoplastic Process
|
6
|
18
|
0.100 |
None |
|
0 |
2
|
|
|
Maffucci Syndrome
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Li-Fraumeni-Like Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |
Fibrofolliculoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
10
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
4
|
|
|
Stage III Breast Cancer AJCC v6
|
disease |
|
Neoplastic Process
|
12
|
1
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2011 |
Stage III Breast Cancer AJCC v7
|
disease |
|
Neoplastic Process
|
12
|
1
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2011 |
Anatomic Stage III Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
12
|
1
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2011 |
Prognostic Stage III Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
12
|
1
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2011 |
Breast cancer stage III
|
disease |
|
Neoplastic Process
|
12
|
1
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2011 |
Inflammation of large intestine
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
12
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Breast Neoplasms, Male
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
14
|
|
0.310 |
None |
1.000 |
2 |
|
2002 |
2008 |